HDAC4 promotes the growth and metastasis of gastric cancer via autophagic degradation of MEKK3
Open Access
- 30 May 2022
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 127 (2) , 237-248
Abstract
Background: Histone deacetylases (HDACs) have been shown to be involved in tumorigenesis, but their precise role and molecular mechanisms in gastric cancer (GC) have not yet been fully elucidated. Methods: Bioinformatics screening analysis, qRT-PCR, and immunohistochemistry (IHC) were used to identify the expression of HDAC4 in GC. In vitro and in vivo functional assays illustrated the biological function of HDAC4. RNA-seq, GSEA pathway analysis, and western blot revealed that HDAC4 activated p38 MAPK signalling. Immunofluorescence, western blot, and IHC verified the effect of HDAC4 on autophagy. ChIP and dual-luciferase reporter assays demonstrated that the transcriptional regulation mechanism of HDAC4 and ATG4B. Results: HDAC4 is upregulated in GC and correlates with poor prognosis. In vitro and in vivo assays showed that HDAC4 contributes to the malignant phenotype of GC cells. HDAC4 inhibited the MEF2A-driven transcription of ATG4B and prevented MEKK3 from p62-dependent autophagic degradation, thus activating p38 MAPK signalling. Reciprocally, the downstream transcription factor USF1 enhanced HDAC4 expression by regulating HDAC4 promoter activity, forming a positive feedback loop and continuously stimulating HDAC4 expression and p38 MAPK signalling activation. Conclusion: HDAC4 plays an oncogenic role in GC, and HDAC4-based targeted therapy would represent a novel strategy for GC treatment.Keywords
This publication has 42 references indexed in Scilit:
- Islet-1 May Function as an Assistant Factor for Histone Acetylation and Regulation of Cardiac Development-Related Transcription Factor Mef2c ExpressionPLOS ONE, 2013
- Class IIa HDACs repressive activities on MEF2‐depedent transcription are associated with poor prognosis of ER + breast tumorsThe FASEB Journal, 2012
- Expression characterization and the promoter activity analysis of zebrafish hdac4Fish Physiology and Biochemistry, 2011
- Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cellsBreast Cancer Research and Treatment, 2011
- Pathological roles of MAPK signaling pathways in human diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- The many roles of histone deacetylases in development and physiology: implications for disease and therapyNature Reviews Genetics, 2009
- Prognosis of pN3 Stage Gastric CancerCancer Research and Treatment, 2009
- Inhibition of Histone Deacetylation: A Strategy for Tumor RadiosensitizationJournal of Clinical Oncology, 2007
- The Usf‐1 transcription factor is a novel target for the stress‐responsive p38 kinase and mediates UV‐induced Tyrosinase expressionThe EMBO Journal, 2001
- mHDA1/HDAC5 Histone Deacetylase Interacts with and Represses MEF2A Transcriptional ActivityJournal of Biological Chemistry, 2000